[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4968 followers Created: 2025-07-18 19:03:41 UTC 🦉 Even without official approval, more patients are trying GLP-1s for T1D. The spotlight is finally shifting from insulin alone to newer, longer-acting and smarter treatments that could change the game. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1 XXX engagements  **Related Topics** [hims](/topic/hims) [pfe](/topic/pfe) [manat](/topic/manat) [$hims](/topic/$hims) [$vani](/topic/$vani) [$zldpf](/topic/$zldpf) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [Post Link](https://x.com/AponiaAnalytics/status/1946284757374963963)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4968 followers
Created: 2025-07-18 19:03:41 UTC
🦉 Even without official approval, more patients are trying GLP-1s for T1D. The spotlight is finally shifting from insulin alone to newer, longer-acting and smarter treatments that could change the game. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #diabetes #GLP1
XXX engagements
Related Topics hims pfe manat $hims $vani $zldpf $rhhby $gsk
/post/tweet::1946284757374963963